Dutch scientists defend patenting of Saudi coronavirus | HHS forms strategic alliance to develop new antibiotics | Universal flu jab edges closer | Saudis to send animal samples to U.S. in MERS-CoV probe | DHS Science & Technology project roundup | Germans find new evidence of shady Soviet-Era drug trials | Patent-protected technology ended up on FDA website, companies charge | Sen. Roberts: NBAF construction set to begin | Unusual pathogens ruled out in Alabama illness cluster | New Indian rotavirus vaccine provides hope | Government biodefense advisor profited from anthrax drug maker | A structural revolution | SARS 10 years later
See what we’re reading this week at Global Biodefense on topics like NBAF construction, the new rotavirus vaccine, emerging coronavirus patent, universal flu vaccines and more…
Dutch scientists defend patenting of Saudi coronavirus (Bloomberg)
HHS forms strategic alliance to develop new antibiotics (HHS)
Universal flu jab edges closer (BBC News)
Saudis to send animal samples to U.S. in MERS-CoV probe (CIDRAP)
DHS Science & Technology project roundup (DHS)
Germans find new evidence of shady Soviet-Era drug trials (BusinessWeek)
Patent-protected technology ended up on FDA website, companies charge (FSN)
Sen. Roberts: NBAF construction set to begin (KCUR)
Unusual pathogens ruled out in Alabama illness cluster (CIDRAP)
New Indian rotavirus vaccine provides hope (NIH Fogarty)
Government biodefense advisor profited from anthrax drug maker (NTI GSN)
A structural revolution (Howard Hughes Medical Institute)
SARS 10 years later (CDC)